1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Vakonakis, I.
Campbell, I.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Embo J.
EMJODG
0897
0261-4189
26
2575
2583
10.1038/sj.emboj.7601694
17464288
Interdomain association in fibronectin: insight into cryptic sites and fibrillogenesis.
2007
10.2210/pdb2h41/pdb
pdb_00002h41
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
10202.056
Fibronectin
Fibronectin type-III 2(2F3)
1
man
polymer
FN, Cold-insoluble globulin, CIG
no
no
GPLGSHLVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQIS
EDGEQSLILSTSQTT
GPLGSHLVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQIS
EDGEQSLILSTSQTT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
FN1
9606
Homo sapiens
562
Escherichia coli
BL21(DE3)-RP
plasmid
pGEX-6P-2
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2007-04-10
1
1
2008-05-01
1
2
2011-07-13
1
3
2022-03-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
1H, 13C and 15N chemical shift assignments
25 models for the same protein
HELIX (no helix)
DETERMINATION METHOD: AUTHOR DETERMINED
RCSB
Y
PDBJ
2006-05-23
REL
REL
1
3D_15N-separated_NOESY
HNHA
4D_13C-separated_NOESY
HNHB
15N IPAP-HSQC
C-C long range couplings
Methyl - carbonyl couplings
Methyl - nitrogen couplings
HACAHB
20mM NaCl, 20mM Na2HPO4
7.0
ambient
303
K
Structure based on 2827 restraints
Simulated annealing in cartesian space
minimized average structure
2.5mM 2F3 U-15N, 20mM NaPi pH 7.0, 20mM NaCl, 95% H2O, 5% D2O
95% H2O/5% D2O
2mM 2F3 U-13C,15N, 20mM NaPi pH 7.0, 20mM NaCl, 95% H2O, 5% D2O
95% H2O/5% D2O
2mM 2F3 U-13C,15N, 20mM NaPi pH 7.0, 20mM NaCl, 100% D2O
100% D2O
1mM 2F3 U-15N, 20mM NaPi pH 7.0, 20mM NaCl, 4% Radially compressed polyacrylamide gel, 95% H2O, 5% D2O
95% H2O/5% D2O
GE/Bruker
collection
Omega
Beta 6.0.3b2
Frank Delaglio, NIH/NIDDK/LCP
processing
NMRPipe
2.3 Rev 2005.319.11.22
Dan Garrett, NIH/NIDDK/LCP
data analysis
PIPP
4.3.7
Schwieters, Kuszewski, Tjandra, Clore, NIH/NIDDK/LCP
structure solution
XPLOR-NIH
2.12
Schwieters, Kuszewski, Tjandra, Clore, NIH/NIDDK/LCP
refinement
XPLOR-NIH
2.12
500
Home-built
Home built
600
Home-built
Home built
GLY
1
n
1
GLY
1
A
PRO
2
n
2
PRO
2
A
LEU
3
n
3
LEU
3
A
GLY
4
n
4
GLY
4
A
SER
5
n
5
SER
5
A
HIS
6
n
6
HIS
6
A
LEU
7
n
7
LEU
7
A
VAL
8
n
8
VAL
8
A
ALA
9
n
9
ALA
9
A
THR
10
n
10
THR
10
A
SER
11
n
11
SER
11
A
GLU
12
n
12
GLU
12
A
SER
13
n
13
SER
13
A
VAL
14
n
14
VAL
14
A
THR
15
n
15
THR
15
A
GLU
16
n
16
GLU
16
A
ILE
17
n
17
ILE
17
A
THR
18
n
18
THR
18
A
ALA
19
n
19
ALA
19
A
SER
20
n
20
SER
20
A
SER
21
n
21
SER
21
A
PHE
22
n
22
PHE
22
A
VAL
23
n
23
VAL
23
A
VAL
24
n
24
VAL
24
A
SER
25
n
25
SER
25
A
TRP
26
n
26
TRP
26
A
VAL
27
n
27
VAL
27
A
SER
28
n
28
SER
28
A
ALA
29
n
29
ALA
29
A
SER
30
n
30
SER
30
A
ASP
31
n
31
ASP
31
A
THR
32
n
32
THR
32
A
VAL
33
n
33
VAL
33
A
SER
34
n
34
SER
34
A
GLY
35
n
35
GLY
35
A
PHE
36
n
36
PHE
36
A
ARG
37
n
37
ARG
37
A
VAL
38
n
38
VAL
38
A
GLU
39
n
39
GLU
39
A
TYR
40
n
40
TYR
40
A
GLU
41
n
41
GLU
41
A
LEU
42
n
42
LEU
42
A
SER
43
n
43
SER
43
A
GLU
44
n
44
GLU
44
A
GLU
45
n
45
GLU
45
A
GLY
46
n
46
GLY
46
A
ASP
47
n
47
ASP
47
A
GLU
48
n
48
GLU
48
A
PRO
49
n
49
PRO
49
A
GLN
50
n
50
GLN
50
A
TYR
51
n
51
TYR
51
A
LEU
52
n
52
LEU
52
A
ASP
53
n
53
ASP
53
A
LEU
54
n
54
LEU
54
A
PRO
55
n
55
PRO
55
A
SER
56
n
56
SER
56
A
THR
57
n
57
THR
57
A
ALA
58
n
58
ALA
58
A
THR
59
n
59
THR
59
A
SER
60
n
60
SER
60
A
VAL
61
n
61
VAL
61
A
ASN
62
n
62
ASN
62
A
ILE
63
n
63
ILE
63
A
PRO
64
n
64
PRO
64
A
ASP
65
n
65
ASP
65
A
LEU
66
n
66
LEU
66
A
LEU
67
n
67
LEU
67
A
PRO
68
n
68
PRO
68
A
GLY
69
n
69
GLY
69
A
ARG
70
n
70
ARG
70
A
LYS
71
n
71
LYS
71
A
TYR
72
n
72
TYR
72
A
ILE
73
n
73
ILE
73
A
VAL
74
n
74
VAL
74
A
ASN
75
n
75
ASN
75
A
VAL
76
n
76
VAL
76
A
TYR
77
n
77
TYR
77
A
GLN
78
n
78
GLN
78
A
ILE
79
n
79
ILE
79
A
SER
80
n
80
SER
80
A
GLU
81
n
81
GLU
81
A
ASP
82
n
82
ASP
82
A
GLY
83
n
83
GLY
83
A
GLU
84
n
84
GLU
84
A
GLN
85
n
85
GLN
85
A
SER
86
n
86
SER
86
A
LEU
87
n
87
LEU
87
A
ILE
88
n
88
ILE
88
A
LEU
89
n
89
LEU
89
A
SER
90
n
90
SER
90
A
THR
91
n
91
THR
91
A
SER
92
n
92
SER
92
A
GLN
93
n
93
GLN
93
A
THR
94
n
94
THR
94
A
THR
95
n
95
THR
95
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
PHE
22
A
N
PHE
22
A
O
ILE
63
A
O
ILE
63
A
O
LEU
54
A
O
LEU
54
A
N
PHE
36
A
N
PHE
36
A
N
SER
34
A
N
SER
34
A
O
ILE
79
A
O
ILE
79
A
N
VAL
76
A
N
VAL
76
A
O
LEU
89
A
O
LEU
89
1
A
A
HD12
ND1
LEU
HIS
3
6
0.50
1
A
A
CD1
ND1
LEU
HIS
3
6
0.80
1
A
A
O
H
SER
SER
28
30
0.84
1
A
A
HG
H
SER
LEU
5
7
0.89
1
A
A
OE1
HH21
GLU
ARG
45
70
0.89
1
A
A
CD1
HD1
LEU
HIS
3
6
0.97
1
A
A
C
H
HIS
VAL
6
8
0.99
1
A
A
O
H
GLU
VAL
12
14
1.00
1
A
A
O
H
HIS
VAL
6
8
1.04
1
A
A
HD13
HD1
LEU
HIS
3
6
1.04
1
A
A
HD12
CG
LEU
HIS
3
6
1.05
1
A
A
HD12
HD1
LEU
HIS
3
6
1.08
1
A
A
HG
NE2
LEU
HIS
3
6
1.08
1
A
A
CD
HH21
GLU
ARG
45
70
1.09
1
A
A
HG
CE1
LEU
HIS
3
6
1.10
1
A
A
O
HG21
ALA
THR
9
10
1.14
1
A
A
O
H
PRO
SER
2
5
1.15
1
A
A
OD1
H
ASP
GLU
47
48
1.15
1
A
A
C
H
GLU
VAL
12
14
1.27
1
A
A
O
N
HIS
VAL
6
8
1.28
1
A
A
O
H
VAL
ALA
27
29
1.33
1
A
A
O
N
GLU
VAL
12
14
1.33
1
A
A
H
O
SER
ILE
34
79
1.35
1
A
A
HD13
ND1
LEU
HIS
3
6
1.37
1
A
A
O
HG13
THR
ILE
15
17
1.43
1
A
A
O
HB3
GLY
SER
4
5
1.44
1
A
A
O
H
LEU
ALA
7
9
1.46
1
A
A
HG
OD1
SER
ASP
80
82
1.46
1
A
A
O
H
PRO
GLY
2
4
1.49
1
A
A
H
O
PHE
LEU
36
54
1.53
1
A
A
C
HE2
PRO
HIS
2
6
1.53
1
A
A
CG
CE1
LEU
HIS
3
6
1.53
1
A
A
HB2
CD2
LEU
HIS
3
6
1.54
1
A
A
O
HD21
PHE
ASN
22
62
1.54
1
A
A
C
H
PRO
GLY
2
4
1.59
1
A
A
CG2
H
THR
SER
10
11
1.60
1
A
A
O
H
THR
ILE
15
17
1.60
1
A
A
O
N
PRO
GLY
2
4
1.60
1
A
A
OD1
OE1
ASP
GLU
47
48
1.61
1
A
A
CD1
CE1
LEU
HIS
3
6
1.63
1
A
A
OD1
CD
ASP
GLU
47
48
1.65
1
A
A
O
OG
GLU
SER
16
21
1.67
1
A
A
O
O
GLY
ASP
46
47
1.69
1
A
A
O
N
LEU
ALA
7
9
1.70
1
A
A
O
N
SER
SER
28
30
1.77
1
A
A
O
CG2
ALA
THR
9
10
1.79
1
A
A
OG
OD1
SER
ASP
80
82
1.80
1
A
A
OE1
NH2
GLU
ARG
45
70
1.82
1
A
A
OE2
NH2
GLU
ARG
45
70
1.83
1
A
A
C
N
HIS
VAL
6
8
1.84
1
A
A
CG
ND1
LEU
HIS
3
6
1.85
1
A
A
CD1
CG
LEU
HIS
3
6
1.86
1
A
A
CG
NE2
LEU
HIS
3
6
1.90
1
A
A
CD
NH2
GLU
ARG
45
70
1.92
1
A
A
O
N
THR
ILE
15
17
1.99
1
A
A
O
N
PRO
SER
2
5
2.03
1
A
A
C
N
GLU
VAL
12
14
2.06
1
A
A
CB
CD2
LEU
HIS
3
6
2.14
1
A
A
O
CA
HIS
VAL
6
8
2.15
1
A
A
C
N
PRO
GLY
2
4
2.19
1
A
LEU
3
21.40
19.17
1
A
SER
5
116.28
-37.19
1
A
HIS
6
56.86
15.67
1
A
LEU
7
29.80
-3.21
1
A
VAL
8
12.30
-49.29
1
A
ALA
9
-26.42
-80.38
1
A
THR
10
102.52
-108.06
1
A
SER
11
-37.91
113.97
1
A
GLU
12
-9.35
72.96
1
A
SER
13
-18.93
-7.54
1
A
THR
15
-93.39
-76.62
1
A
GLU
16
-35.83
69.23
1
A
ALA
19
54.11
16.81
1
A
SER
28
-57.88
58.24
1
A
ALA
29
-38.07
24.48
1
A
SER
30
179.22
128.80
1
A
GLU
44
-109.87
-69.65
1
A
ASP
47
-27.99
-171.71
minimized average
Solution structure of the second type III domain of human Fibronectin: minimized average structure
1
N
N
A
PRO
2
A
PRO
2
HELX_P
A
HIS
6
A
HIS
6
5
1
5
A
ILE
17
A
ILE
17
HELX_P
A
SER
21
A
SER
21
5
2
5
CELL ADHESION, STRUCTURAL PROTEIN
beta sandwich, CELL ADHESION, STRUCTURAL PROTEIN
FINC_HUMAN
UNP
1
721
P02751
LVATSESVTEITASSFVVSWVSASDTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNVYQISEDGEQS
LILSTSQTT
721
809
2H41
7
95
P02751
A
1
7
95
1
cloning artifact
GLY
1
2H41
A
P02751
UNP
1
1
cloning artifact
PRO
2
2H41
A
P02751
UNP
2
1
cloning artifact
LEU
3
2H41
A
P02751
UNP
3
1
cloning artifact
GLY
4
2H41
A
P02751
UNP
4
1
cloning artifact
SER
5
2H41
A
P02751
UNP
5
1
cloning artifact
HIS
6
2H41
A
P02751
UNP
6
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
PHE
22
A
PHE
22
A
SER
25
A
SER
25
A
SER
60
A
SER
60
A
ILE
63
A
ILE
63
A
GLN
50
A
GLN
50
A
PRO
55
A
PRO
55
A
VAL
33
A
VAL
33
A
LEU
42
A
LEU
42
A
LYS
71
A
LYS
71
A
SER
80
A
SER
80
A
GLN
85
A
GLN
85
A
THR
94
A
THR
94